Home

Aetiology

Read time: 3 min

Congress highlights

Potential new targets in depression and schizophrenia – learnings from obesity and exercise

Weight loss and exercise increase benefit for mental health, but are difficult to achieve....

Alzheimer's Disease

Read time: 3 min

Congress highlights

Encouraging immune response to AD: adjuvants, modifying the microbiome, and microglial rejuvenation

Modulating central and peripheral innate immunity has potential in Alzheimer’s Disease....

Read time: 3 min

One size does not fit all…or does it?: Heterogeneity within depression

Depressive disorders are “the world’s most important cause of disability”, as...

Parkinson's Disease

Read time: 3 min

Congress highlights

What the brain teaches us about α-synuclein

In all affected brain regions, α-synuclein accumulates only in specific cell types, and only in...

Parkinson's Disease

Read time: 4 min

Congress highlights

Synucleinopathies see advances in biomarkers and imaging

Improved diagnostics and insights into pathogenesis were presented in the ADPD session that...

Depression, Schizophrenia

Read time: 3 min

The evolving science of psychiatry

Science is beginning to reinforce the practice of psychiatry through increasing understanding of...

Read time: 4 min

Refining and redefining diagnosis and prognosis in psychosis: can biomarkers and imaging help?

Consortia the world over are seeking biomarkers, including abnormalities on brain imaging, that...

Read time: 3 min

Schizophrenia: more same than different to neurodevelopmental disorders?

Rather than a discrete entity, schizophrenia sits on a neurodevelopmental continuum of disorders...

Alzheimer's Disease

Read time: 3 min

Vulnerability and resilience in Alzheimer’s Disease

Early life stress aggravates Alzheimer’s Disease (AD) pathology and early life enrichment...

Does glutamate hold the key to unlocking major depressive disorder?

Read the full feature here. Download the audio file.

Does glutamate hold the key to unlocking major depressive disorder?

Bipolar, Schizophrenia

Read time: 3 min

Highlighted studies in psychosis

New light cast on links between mental illness and creativity; inflammatory pathways that may be...

Read time: 3 min

Does glutamate hold the key to unlocking major depressive disorder?

Despite over 50 years of drug development in major depressive disorder (MDD), patients and their...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country